Loading provider…
Loading provider…
Ophthalmology Physician in Lawrenceville, GA
NPI: 1447288246Primary Employer
Jonathan Woolfson, MD, PC
woolfsoneye.com
HQ Phone
Get M.D. Douglas's Phone Numberphone_androidMobile
Get M.D. Douglas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92083Measurement of field of vision during daylight conditions | 1,118 | 1,129 |
| 2 | 92133Diagnostic imaging of optic nerve of eye | 1,040 | 1,061 |
| 3 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 947 | 1,120 |
| 4 | 92012Eye and medical examination for diagnosis and treatment, established patient | 738 | 1,144 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 235 | 295 |
Authors: Day, Douglas G, Hollander, David A
Journal: Curr Med Res Opin
Publication Date: 2008-04-09
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients.
Authors: Damien Goldberg, Earl Craven, Margot Goodkin
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion